Literature DB >> 3735507

Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma.

R G Middleton, J A Smith, R B Melzer, P E Hamilton.   

Abstract

From 1970 to 1980, 153 patients with stages A2, B1 and B2 prostatic cancer and proved negative pelvic lymph nodes underwent radical prostatectomy (84 underwent radical perineal and 69 underwent radical retropubic prostatectomy). Seventeen patients were lost to followup. Of 136 patients who were followed for 5 years or until death 128 (94 per cent) were alive at 5 years, including 118 (87 per cent) who were without evidence of recurrence. Patients with microscopic invasion of the prostatic capsule have a better outcome at 5 years than those with microscopic involvement of the seminal vesicles. Only 46 of the patients could be assessed at 10 years or had died 6 to 10 years postoperatively. Results at 10 years are considered preliminary, since many more patients will reach the 10-year milestone within the next few years.

Entities:  

Mesh:

Year:  1986        PMID: 3735507     DOI: 10.1016/s0022-5347(17)44890-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens.

Authors:  C Bartolozzi; I Menchi; R Lencioni; S Serni; A Lapini; G Barbanti; A Bozza; A Amorosi; A Manganelli; M Carini
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Iodine 125 interstitial irradiation for localized prostate cancer.

Authors:  P P Kumar; R R Good; F F Bartone
Journal:  J Natl Med Assoc       Date:  1990-03       Impact factor: 1.798

3.  Influence of preoperative vesicle biopsy on the decision for radical prostatectomy.

Authors:  C H Deliveliotis; J Varkarakis; N Trakas; G Louras; S Giannakopoulos; A Skolarikos; E Alargof
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.